Methylfenidaat Hcl Viatris (Methylphenidate Hydrochloride)

Methylphenidate acts on central nervous system pathways involved in attention and wakefulness, and is indicated for the following conditions:

• ADHD (children): improves concentration and reduces hyperactive behavior
• ADHD (adults): enhances focus and decreases impulsivity
• Narcolepsy: decreases daytime sleepiness and improves wakefulness

• Methylphenidate blocks the reuptake of dopamine and norepinephrine by inhibiting the dopamine transporter (DAT) and norepinephrine transporter (NET) in neuronal synapses. This increases the extracellular concentrations of these catecholamines, enhancing neurotransmission in brain regions that regulate attention, impulse control and arousal, thereby producing its therapeutic effects. The elevated catecholamine levels modulate activity in the prefrontal cortex and basal ganglia, which are critical for executive function and motor activity.

Methylphenidate may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

• Insomnia: difficulty falling or staying asleep
• Decreased appetite: reduced hunger leading to weight loss
• Headache: mild to moderate cranial pain
• Stomach pain: abdominal discomfort or nausea

Serious or Rare Side Effects

• Cardiovascular events: chest pain, hypertension, or arrhythmia
• Psychosis: hallucinations, delusional thinking, or severe agitation
• Severe allergic reaction: rash, swelling, or anaphylaxis

Before prescribing methylphenidate, clinicians should consider several safety precautions to minimize risks.

• Assess cardiovascular status: evaluate blood pressure and heart rate before initiating therapy
• Monitor growth in children: track height and weight regularly during treatment
• Avoid use in severe anxiety or psychosis: may exacerbate these conditions
• Consider drug holidays: periodic breaks can reduce impact on growth
• Avoid abrupt discontinuation: taper under medical supervision to prevent rebound symptoms
• Store at ambient temperature: keep in the original container, protect from moisture and light

Methylphenidate can interact with other medicines, affecting its safety or effectiveness.

Major Interactions (Avoid)

• MAO inhibitors: concurrent use may cause hypertensive crisis
• Tricyclic antidepressants: may increase cardiovascular side effects
• Antihypertensive agents: methylphenidate can reduce their blood‑pressure‑lowering effect

Moderate Interactions (Monitor Closely)

• Anticonvulsants: may lower methylphenidate plasma levels
• CYP2D6 inhibitors: can raise methylphenidate exposure
• Alcohol: may enhance central nervous system stimulation